Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07688551 · ClinicalTrials.gov registry record · Phase 2

Superiority Trial of Aphasia-focused Rehabilitation With tDCS Stimulation

A Phase 2 study, sponsored by University of South Carolina.

Not yet
Registry status
Phase 2
Development phase
130
Enrollment target

NCT07688551: Clinical Trial Phase 2 study, sponsored by University of South Carolina.

NCT07688551 is a Phase 2 study that has not yet begun recruiting, run by University of South Carolina. The registered enrollment target is 130 participants, roughly in line with the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07688551, a Phase 2 study, has not yet begun recruiting, sponsored by University of South Carolina.

NOT YET RECRUITING
Registry status
Phase 2
Development phase
130 participants
Enrollment target

Study Summary

The purpose of this study is to help us understand if adding transcranial Direct Current Stimulation (tDCS), a non-invasive brain stimulation technique, to Speech Therapy improves language recovery in people with Broca's aphasia and is more effective than Speech Therapy alone.

Primary Outcome

Change in the number of correctly named items between the average of the two pre-treatment Philadelphia Naming Test (PNT) assessments and the average of the two post-treatment PNT sessions at 4-weeks post treatment.

Interventions

  • DEVICE tDCS

Trial Details

FieldValue
Enrollment Target 130 participants
Start Date 2026-07-31
Est. Completion 2030-06
Phase Phase 2
University of South Carolina

157 total trials

What is known before NCT07688551 opens enrollment

NCT07688551 is an interventional study that assigns participants to a tested intervention. The registered 130 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target.

The record links to 0 conditions, and to 1 intervention - of which tDCS is the first listed.

NCT07688551 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07688551 about?

NCT07688551 is a clinical study titled "Superiority Trial of Aphasia-focused Rehabilitation With tDCS Stimulation". The purpose of this study is to help us understand if adding transcranial Direct Current Stimulation (tDCS), a non-invasive brain stimulation technique, to Speech Therapy improves language recovery in people with Broca's aphasia and is more effective than Speech Therapy alone.

What is the current status of trial NCT07688551?

This trial is currently not yet recruiting. It is a Phase 2 study. The enrollment target is 130 participants. The study started on 2026-07-31. Estimated completion is 2030-06.

What interventions are being tested in trial NCT07688551?

The interventions under investigation include: tDCS (DEVICE).

Who is sponsoring clinical trial NCT07688551?

This trial is sponsored by University of South Carolina, which has 157 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07688551's enrollment target sits among peer trials

130 543rd of 2000 higher than 1,448 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01492036 · 130 participants

    Long-Term Follow-Up of Recipient of Gene Transfer Research

  • NCT01631617 · 130 participants · Phase 2

    Effects of Treatments on Atopic Dermatitis

  • NCT02368041 · 130 participants

    Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure

  • NCT02604277 · 130 participants · NA

    Suicidal Behavior in Patients Diagnosed With Bipolar Disorder

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07688551, the US trial registry maintained by the National Library of Medicine. NCT07688551 (mid enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.